Cardiovascular

Raw Deal for European Women with Coronary Artery Disease

Caroline Daly
Caroline Daly

The Euroheart survey has found significant differences in both diagnosis and treatment of heart disease in women as compared with men. Audio Medica asked Caroline Daly of London’s Royal Brompton Hospital about the clinical implications.

Click here for all the interviews from ESC 2005

Similar Interviews

  • Eicosapentaenoic Acid: Prevention of Coronary Artery Disease
  • A 20 000-person study of eicosapentaenoic acid supplements gave solid scientific support for EPA use to prevent cardiovascular events among

  • Protective Cardiovascular Benefit for Women on HRT For Natural Menopause
  • George Sopko REFERENCE: Abstract 3771, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida

  • Pexelizumab Reduces Mortality in High Risk Coronary Artery By-Pass Patients
  • Peter Smith, Duke University Medical Center, Durham, NC Late Breaking Clinical Trials, ACC Atlanta 2006, Sunday 12th March 2006 The drug pexelizumab,

    Post a comment

    Subscribe to Audio Medica Podcast